Acumen Pharmaceuticals is based out of Charlottesville. Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target amyloid-beta oligomers, (A��Os), which Acumen believes to be a key underlying cause of Alzheimer���s disease. The firm last filed a Form D notice of exempt offering of securities on 2013-05-15. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
Acumen Pharmaceuticals, Inc.427 PARK ST.
CHARLOTTESVILLE VA 22902
Business Phone: 925-368-8508
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)